Borongosam, Binasing M.

HRN: 16-92-31  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/16/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/17/2024
10/23/2024
IV
2.25G
TID
CAPMR, SKIN INFECTION
Waiting Final Action 

Indication:  Empiric    Type of Infection:  PneumoniaSkin & Soft TissueMultiple Infections (tick All Sites)    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: